IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every thirty pre-consolidated Common Shares (the "Consolidation").

 

The Board has authorized the Consolidation to be effected on or before September 15, 2026, with the Company currently expecting August 27, 2026 to be the effective date of the Consolidation (the "Effective Date"). The Company anticipates that the Common Shares will begin trading on the Nasdaq Capital Market ("Nasdaq") on a post-Consolidation basis at the opening of trading on August 27, 2026, subject to final confirmation from Nasdaq and completion of applicable corporate, transfer agent and market implementation processes.